Your browser is no longer supported. Please, upgrade your browser.
CDXC ChromaDex Corporation monthly Stock Chart
ChromaDex Corporation
Index- P/E- EPS (ttm)-0.38 Insider Own0.10% Shs Outstand61.70M Perf Week-2.40%
Market Cap293.11M Forward P/E- EPS next Y-0.18 Insider Trans9.10% Shs Float38.34M Perf Month2.30%
Income-22.70M PEG- EPS next Q-0.09 Inst Own24.90% Short Float6.25% Perf Quarter8.19%
Sales56.90M P/S5.15 EPS this Y7.00% Inst Trans8.38% Short Ratio7.20 Perf Half Y5.84%
Book/sh0.32 P/B15.28 EPS next Y41.90% ROA-58.40% Target Price7.90 Perf Year30.75%
Cash/sh0.26 P/C18.91 EPS next 5Y- ROE-116.20% 52W Range2.50 - 6.00 Perf YTD13.46%
Dividend- P/FCF- EPS past 5Y-30.00% ROI- 52W High-18.50% Beta1.50
Dividend %- Quick Ratio1.50 Sales past 5Y24.80% Gross Margin58.60% 52W Low95.60% ATR0.22
Employees110 Current Ratio2.40 Sales Q/Q17.40% Oper. Margin-39.80% RSI (14)49.40 Volatility3.61% 4.72%
OptionableYes Debt/Eq0.01 EPS Q/Q45.30% Profit Margin-39.90% Rel Volume0.47 Prev Close4.85
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume332.45K Price4.89
Recom1.60 SMA20-0.03% SMA503.14% SMA2008.66% Volume155,450 Change0.82%
Oct-16-19Initiated Oppenheimer Outperform $6
Feb-14-19Initiated B. Riley FBR Buy $7
Nov-27-17Resumed H.C. Wainwright Buy $6 → $8
Sep-25-17Initiated Ladenburg Thalmann Buy $7
Jan-03-17Initiated Rodman & Renshaw Buy $6
Dec-02-20 03:49PM  
Nov-17-20 06:35AM  
Nov-09-20 06:32AM  
Nov-07-20 08:32AM  
Nov-04-20 11:32PM  
Nov-03-20 10:09AM  
Oct-28-20 06:35AM  
Oct-27-20 10:22AM  
Oct-19-20 06:32AM  
Oct-14-20 09:10AM  
Oct-08-20 06:32AM  
Oct-07-20 04:30AM  
Oct-06-20 06:35AM  
Sep-09-20 06:33AM  
Sep-01-20 04:34PM  
Aug-26-20 06:32AM  
Aug-18-20 06:32AM  
Aug-06-20 07:10PM  
Aug-05-20 09:00AM  
Jul-30-20 12:33PM  
Jul-28-20 06:32AM  
Jul-16-20 06:33AM  
Jul-14-20 06:32AM  
Jul-09-20 06:36AM  
Jul-07-20 06:34AM  
Jun-30-20 06:32AM  
Jun-17-20 06:33AM  
Jun-16-20 06:32AM  
Jun-15-20 09:42PM  
Jun-03-20 06:33AM  
Jun-01-20 06:32AM  
May-27-20 03:15PM  
May-21-20 06:32AM  
May-12-20 01:01AM  
May-11-20 05:25PM  
May-06-20 06:32AM  
May-01-20 06:32AM  
Apr-28-20 06:33AM  
Apr-27-20 06:47AM  
Apr-24-20 08:47AM  
Apr-23-20 06:32AM  
Apr-20-20 06:32AM  
Apr-14-20 06:32AM  
Mar-23-20 06:30AM  
Mar-16-20 07:32AM  
Mar-13-20 06:57AM  
Mar-12-20 04:44PM  
Mar-10-20 05:15PM  
Mar-03-20 12:30PM  
Feb-27-20 06:30AM  
Feb-25-20 06:30AM  
Feb-12-20 06:30AM  
Feb-03-20 06:30AM  
Jan-15-20 06:30AM  
Jan-06-20 06:30AM  
Dec-30-19 02:01PM  
Dec-23-19 10:24AM  
Dec-16-19 06:30AM  
Dec-11-19 06:30AM  
Dec-05-19 06:30AM  
Dec-02-19 06:30AM  
Dec-01-19 10:27PM  
Nov-20-19 06:30AM  
Nov-12-19 07:55PM  
Nov-11-19 08:38AM  
Nov-05-19 10:31AM  
Nov-04-19 06:30AM  
Oct-31-19 06:30AM  
Oct-30-19 10:34AM  
Oct-17-19 06:30AM  
Oct-11-19 06:30AM  
Oct-07-19 06:30AM  
Sep-26-19 06:30AM  
Sep-10-19 08:00AM  
Aug-15-19 10:16PM  
Aug-14-19 09:10AM  
Aug-08-19 12:34AM  
Aug-07-19 07:05PM  
Aug-06-19 04:05PM  
Aug-01-19 10:33AM  
Jul-31-19 04:05PM  
Jul-24-19 06:30AM  
Jul-23-19 06:30AM  
Jul-08-19 09:29AM  
Jun-05-19 06:30AM  
ChromaDex Corporation operates as a nutraceutical company. The company offers Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide (NAD) level used for healthy aging; and Immulina, a spirulina extract and compound, which is used for improving human immune function. It also provides reference standards and fine chemicals to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, and pharmaceutical industries. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FARR KEVIN MCHIEF FINANCIAL OFFICERNov 06Buy4.435,00022,15041,625Nov 06 04:20 PM